Connect with us

Hi, what are you looking for?

High Times


Cannabis Research Pioneer, Dr. Raphael Mechoulam, Makes Impassioned Call for Clinical Trials

On Tuesday during a live discussion at the High Times Business Summit, Dr. Raphael Mechoulam, known as the “Father of THC,” made an impassioned plea for good clinical trials to study the effects of medical marijuana on cancer.

A pioneer in research on the medical uses of cannabis, Mechoulam has spent four decades studying and observing the positive effects of cannabis on many of the most pressing medical conditions of our time, including Alzheimer’s disease, epilepsy, cancer and pain management.

“A huge number of people use cannabis for a variety of cancers,” Mechoulam explained to Summit attendees. “Some of them state that this is the only thing that helped them. Maybe? Maybe not. We don’t have a single, good clinical trial in cancers. Any cancers! This is a shame. But there we are.”

“We know that cannabis, or some cannabinoids are pretty good in some types of pain, but again, we don’t have good clinical trials,” he continued. “As a matter of fact, we barely have ANY clinical trials! We need clinical trials! Work in mice is fine but we have to advance.”

Mechoulam, who spoke via video conferencing, was being presented with a lifetime achievement award by High Times when he made his ardent appeal.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


HT Newsletter

Subscribe for exclusive access to deals, free giveaways and more!

Thank you for subscribing.

Something went wrong.


You May Also Like


Ecuador's government recently passed legislation approving medical cannabis containing less than 1% THC.


Virtual visits promise to make the process of getting a medical marijuana card faster and more convenient.


Court watchers were quick to note that, while unanimous, the state Supreme Court’s ruling was still fairly narrow.


Those in safety-sensitive occupations would be exempt from the bill, which also does not allow for the use of cannabis while on the job.


The products have been recalled because they contain unspecified microbials, which were not processed correctly.


The new identification card system should also make editing information on the cards more efficient.


Senate Bill 305 would allow terminally ill patients in California to use medical cannabis in hospitals, while Senate Bill 34 would allow licensed dispensaries...


The project will be subsidized by a $3.5 million grant from the National Institute on Drug Abuse, which is a branch of the National...

Do NOT follow this link or you will be banned from the site!